


Mission Statement
EVMA aims to enhance vaccine production capabilities in Egypt and support public health objectives across Africa.
2nd African Vaccine and Other health products Manufacturing Forum: African Leaders Unite to Forge Vaccine Strategies, Spotlighting EVMA
Conference Launch Highlights
On Wednesday, 27 November 2024, the Egyptian Vaccine Manufacturers Alliance (EVMA) proudly hosted its Launch Conference at the prestigious Marriott El Zamalek from 10 AM to 4 PM.
This conference featured the presence of
This conference will feature the presence of:
Governmental Representation
The conference was honored by the presence of key governmental entities, reflecting a unified commitment to advancing vaccine manufacturing in Egypt:
- Ministry of Health and Population (MOHP)
- Egyptian Drug Authority (EDA)
- Unified Procurement Authority (UPA)
Leading Egyptian Vaccine Manufacturers
Egypt’s six prominent vaccine manufacturers presented their achievements and roles in shaping the national vaccine landscape:
- Biogeneric Pharma
- Gennvax
- GYPTO Pharma
- VACSERA
- VBC (Vaccine & Biotechnology City)
- Eva Pharma
Global Technology Transfer Partnerships
The conference showcased strategic collaborations with renowned international technology providers aimed at enhancing local vaccine production capacities. Key partners include:
- Serum Institute of India
- Sanofi Pasteur
- Biological E
- Bilthoven
- CD BIO
- Walvaxx
- Batavia
- AJ Vaccines
- Minhai
Aims of the Conference
The EVMA Launch Conference served as a platform to:
- Strengthen collaboration among governmental, industrial, and international stakeholders.
- Address key challenges and opportunities in vaccine production.
- Advance strategic public health initiatives to establish Egypt as a global leader in vaccine manufacturing.
This landmark event underscored Egypt’s commitment to innovation, collaboration, and excellence in vaccine production, paving the way for future advancements in public health.
Don't miss out on this opportunity
Apply NOW to Africa CDC's Biomanufacturing Fellowship Program
Launched under the Platform for Harmonized African Health Products Manufacturing, this programme supports a bold continental vision to scale up local production of vaccines, diagnostics, and therapeutics—essential for building resilient health systems and reducing Africa’s reliance on external supply.
Deadline: 30 May 2025
This program is eligible for
1. Recent graduates in pharmacy, pharmaceutical sciences, biotechnology, or a related field, seeking to acquire the technical and industrial skills required for vaccine manufacturing.
2. Currently employed in a biomanufacturing company or leading a biomanufacturing initiative at the national level, with a strong ambition to become a leader in the biomanufacturing sector.





